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We have reported in an accompanying paper that kidney transplants to mice 
regularly  produce  an  immune  alteration  toward  donor  antigens  without  any 
other treatment  (1).  This immune alteration takes place over the 1st mo or so 
after the recipient has undergone kidney transplantation  and bilateral nephrec- 
tomy.  In several strain  combinations  in which incompatibility determined  by 
genes of the H-2 system is involved, manifestations of rejection activity directed 
toward the transplant tend to diminish during the early weeks after transplan- 
tation and loss of transplanted  kidneys becomes much less common. 
The mechanism by which this equilibrium between transplant  and recipient 
is  maintained  remains  to  be  established  in  full.  In  our  previous  paper  we 
presented  evidence  that  the  lymphoid  cells  of kidney  transplant  recipients 
which have survived 1 mo or more are able to respond to donor antigens both in 
vivo and in vitro, but that they do so to a lesser degree, as a population, than do 
normal cells. This relative reduction in ability to respond is associated with the 
presence  in the  recipients'  sera of a  substance  which interferes  with the full 
development or expression of an immune response, especially the development 
of killer T cells. 
The present experiments made use of mice with long-term,  well functioning 
kidney transplants  from H-2 incompatible donors. These animals offer a  study 
system in which various methods  of inducing  the immune  destruction  of the 
surviving  organ  can  be tested.  Each  recipient  bears  a  large  mass  of foreign 
tissue which presents well-characterized  antigenic differences to its host.  The 
function  of the  allogeneic  organ  can  be  evaluated  on  a  continuing  basis  by 
measuring  the  blood  urea  nitrogen  level  of its  recipient.  The  experiments 
described  here  include  treatments  in  which  heightened  reactivity  to  donor 
tissue  antigens  was  conferred  by passive immunization  and  also  maneuvers 
which  awakened  the  dormant  responses  of the  host  so  that  the  recipients 
responded more strongly to donor antigens resulting in the acute destruction of 
the transplant. 
* Supported by grants AM-07055  and HL-18646  from the National Institutes of Health, U.  S. 
Public Health Service. Some of the results embodied in this paper were presented in a lecture to 
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Materials and Methods 
Animals.  Inbred mice were used throughout. As described previously (1) strain combinations 
in which incompatibilities were restricted to  a  portion of the H-2  region were employed.  The 
principal test system involved B10.D2 mice as donors and (C57BL/6 × A/J)F~, abbreviated B6AFI, 
mice as recipients. This strain combination involves an incompatibility determined at the K  end 
of the H-2 complex (H-2.31) as well as an incompatibility in the Ia region. Cells from A.SW mice 
were also used in some experiments as they present different 1-1-2 incompatibilities (H-2.7, 12, 19, 
51) to B6AFI recipients from those offered by B10.D2 cells. 
Members of the B10.BR strain were also used in one experiment as a  source of both kidneys 
and lymphoid cells for transplantation to  B6AF~ recipients.  This donor strain is incompatible 
with the recipient strain at the D  end of the H-2 complex (H-2D plus I-C ), the principal antigenic 
difference being H-2.32. Members of this strain are less incompatible with B6AF~ recipients than 
are  B10.D2 mice as skin grafl~ from them have a  median survival time of 16.5  -+  1.1  days  as 
against 13.5 _+ 1.1 days for B10.D2 grafts. 
A third donor strain, the black mutant B6.C-H(zl), abbreviated H(zl), was also used in grafting 
to B6AF~  recipients. Cells from this mutant strain, originally described by Bailey et al.  (2),  are 
known to be capable of provoking proliferative lymphocyte responses in vitro in mixed cultures 
with cells from recipients of the genotype employed in our experiments. Skin grafts are rejected 
promptly.  Nevertheless,  no  evidence  of a  serologically  measurable  immune  response  in  this 
combination has so far been detected (3). Thes  e findings  ~  havebeen confirmed in our laboratory by 
using several techniques for measuring serological immunity by P.  Sugarbakar and H.  Winn, 
personal communication, so that it is clear that the response to the alloantigens involved in this 
strain combination, by comparison with most other strain combinations in which 1"1-2 incompati- 
bility exists, is weighted heavily toward cellular immunity. 
Operative Procedures 
KIDNEY  TRANSPLANTATION.  Kidney  transplantation  was  accomplished  by  direct  vascular 
union as described previously (1). The recipients' kidneys were removed at the time of transplan- 
tation. 
The  survival  of kidney  transplants  was  evaluated  by  the  survival  of their  recipients,  by 
microscopic examination of sections prepared from them at the time of their removal on selected 
days  (see below),  and most sensitively by serial determination of blood urea nitrogen  (BUN)  ~ 
levels by using a standard urease micromethod. The latter determination was of particular value 
in the present experiments because it offered a means whereby transient effects could be detected 
and measured quantitatively. The normal range is considered to be from 15 to 30 rag/100 ml. 
As described previously (1)  about 30% of B6AF1 recipients of B10.D2 kidneys die during the 
first 30  days.  This  occurs because  of the effects of early  rejection activity combined,  in  some 
instances, with the late consequences of technical imperfections such as some degree of ureteral 
obstruction. After about 1 mo the animals enter a relatively steady state and continuing attrition 
of recipients is low  with only 20% more being lost by 100  days.  A  similar pattern of survival 
results when donor kidneys are obtained from the B10.BR and the H(zl) strains. Accordingly, the 
subjects for study  in the  present experiments were confined to recipients which had survived 
kidney transplantation for 4 wk or more and which had BUN levels in the normal range. 
SKIN GRAFTING.  Full thickness grafts of flank or ventral surface skin were placed on recipient 
beds on the lateral thoracic wall as described in detail by Billingham and Medawar (4). 
LYMPHOID CELL SUSPENSIONS.  "Sensitized"  cells  consisted  of lymph  node  and  spleen  cells 
obtained from B6AF~ animals which had rejected B10.D2 skin grafts and which had received an 
intraperitoneal injection of 10  s B10.D2 lymph node and spleen cells from 4 to 7 days after graft 
rejection. The immunized cells were collected 7-14 days thereafter. 
Spleen  and lymph  nodes were  dissociated to  form cell  suspensions by gent~y passing them 
through a  nylon  sieve.  The  cells  were  collected  in  medium  L-15  (Microbiological  Associates, 
Walkersville, Md.), incubated with 0.14M NH4C1 Tris buffer for 5 rain at 37°C to lyse erythrocytes, 
and resuspended in the medium after two washings. The viability of cells in those suspensions 
employed was in excess of 80% as determined by trypan blue dye exclusion. 
Abbreviations  used in  this paper:  BCG,  Bacille of Calmette  and Guerin; BUN,  blood urea 
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HISTOLOGICAL PREPARATIONS.  Tissue  specimens were fixed in  10%  neutral formalin in 50% 
ethanol, cleared in butanol, embedded in paraffin,  and sectioned at 4  ~m before staining with 
hematoxylin and eosin. 
SEROLOGY.  Complement-dependent cytotoxic antibody titers were determined in a  two stage 
test  as  described  previously  (5).  Trypan  blue  dye  exclusion  was  employed  to  determine  cell 
viability.  A  pooled  antiserum  against  B10.D2  strain  antigens  was  prepared  from  repeated 
bleedings of B6AFI female mice after at least four weekly  injections of B10.D2 lymphoid cells. 
This pool had a  cytotoxic titer of 1:512.  Rabbit serum  which had been exhaustively absorbed 
against mouse tissue was used as the source of complement (C) for infusion into mice. 
51Cr RELEASE ASSAY FOR  CELL-MEDIATED CYTOTOXICITY (CMC).  A  modified  version  of the 
Brunner CMC assay, described previously (6), was used to detect the presence of killer cells in the 
spleens of B6AF~ which had received B10.D2 kidney transplants. P815-X2 tumor cells were used 
as 5tCr-labeled targets since they share H-2K  d antigenic determinants with the kidney donor. A 
mixture of lymphoid test cells and tumor target cells, at the appropriate ratios, was centrifuged 
and allowed to incubate for 16-18 h  at 37°C.  The cells were then resuspended and centrifuged and 
the amount of  51Cr label released into the supernates was determined. 
BCG  AND  CYCLOPHOSPHAMIDE.  Bacille of Calmette  and  Gu~rin  (BCG,  Tice strain) was 
obtained from the University of Illinois  Medical Center in vials  containing 2-8 ×  108 viable 
organisms. The BCG  was reconstituted to i ml with sterile  water, and an individual dose  of  0.1  ml 
(approximately 2 × 10  z  organisms) was given intravenously. Cyclophosphamide (CY) from Mead 
Johnson Laboratories, Evansville, Ind. was dissolved in sterile  water (20  mg/ml) and given i.p.  in 
a dose of  4 rag/animal (160 mg/kg). 
Results 
Treatment with Sensitized, Recipient Strain Lymphoid Cells.  Five B6AF1 
recipients of B10.D2 kidneys were used in this experiment. The transplants had 
been  in  place  from  45  to  307  days  and  all  were  functioning  normally.  Two 
recipients received an  intraperitoneal  injection of 108 spleen and  lymph node 
cells from B6AF1  mice previously immunized  to  B10.D2  antigens.  Two addi- 
tional  animals  received a  second injection of the same number of cells on the 
succeeding day, and a  fifth animal received three daily injections of 1.5  ×  10  s 
cells from immunized donors. Fig. 1 shows the effects of these injections on the 
BUN levels of the recipients.  At the first two dosage levels evidence of kidney 
damage was apparent by the 8th-15 th day. The transplanted  kidneys continued 
to support life in their recipients, however, and there was evidence of improve- 
ment in kidney function by about 3 wk after the injections.  The transplant  in 
the mouse which received the largest number of cells from immunized donors 
showed little response. At the doses of cells employed, it is apparent that defi- 
nite damage to the transplant can result but that it did not progress and there 
was evidence of some late repair of function. With increasing doses of cells there 
was no marked increase in the degree of damage to the transplants. 
Treatment  with Alloantibody  to Donor Antigens  with and  without Added 
Complement.  Seven  B6AF~  recipients  of B10.D2  kidneys  were  used  in  this 
experiment.  Recipients received rabbit serum alone  (0.5 ml) as a  source of C, 
B6AF~ anti-B10.D2 serum alone (0.5 ml), or the antiserum followed 6 h later by 
C.  All  injections  were  delivered  intravenously.  As  inspection  of Fig.  2  will 
reveal,  neither  antiserum  nor C  alone appeared to have any effect on kidney 
function  under  the  conditions  of these  experiments  except  in  one  case  (see 
middle panel) in which a sharp BUN elevation occurred by 5 h after C injection. 
This kidney went on to complete destruction. The recipient in this instance was 
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FIG.  i.  The effect  on transplant function of infusions of lymph node and spleen cells 
sensitized to donor (BI0.D2)  antigens. B6AFI recipients  bearing normally functioning 
kidney transplants for  45-307 days  received ascending doses,  as indicated,  of  lymphoid cells 
intraperitoneally. Prompt evidence of  kidney damage, as reflected  in elevations of  BUN 
levels,  is apparent. Considerable improvement of  renal function follows.  With increasing 
cell  dosage (within the limits tested)  there is no evidence of increased kidney damage. 
Indeed, the least  damage was seen at the highest cell  dose. 
(1:256). In five recipients it was found that antibody infusion, followed within a 
few hours by C, would cause very prompt kidney damage with striking elevation 
of BUN levels shortly after the C infusion• Thereafter kidney function returned 
to normal. 
Treatment with Donor Strain Cells with or without BCG and CY.  BCG and 
CY were employed according to a  protocol originally described by Mackaness P.  S.  RUSSELL,  C.  M.  CHASE,  R.  B.  COLVIN,  AND  J.  M.  D.  PLATE  1473 
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FIG. 2.  The effect  of intravenous  infusions of antibody and C  on the function of long- 
surviving B10.D2  kidneys transplanted to B6AF~ recipients.  In the left  panel the BUN 
records of  four  transplant recipients are shown. At time 0  all  received 0.5  ml of  an antibody 
directed to  donor antigens (see  text).  This  did not  influence  the  function of  the  transplanted 
kidneys. In the middle panel six recipients received injections  of  C (0.5  ml of  rabbit  serum 
absorbed with mouse cells).  No effect  was seen except in the case of  one recipient  known to 
have an unusually high titer  of antibody to donor antigens, In the right panel, antibody 
infusion to five  recipients was followed  in 6 h by C. Impairment of  kidney function was 
apparent by elevation of  BUN  levels  in four of  the five  animals within 24 h. This damage 
was transient  and kidney function after  this  treatment returned to normal in all  animals. 
and Lagrange which they devised to alter the state of specific unresponsiveness 
to  sheep  erythrocytes  which  can  be  induced  in  mice  by  large  doses  of this 
antigen (7). 
CONTROL.  TREATMENT WITH  RECIPIENT  CELLS  ALONE.  This control was per- 
formed to rule  out a  possible nonspecific  effect resulting from the injection of 
large  numbers  of  spleen  and  lymph  node  cells  which  might  lodge  in  the 
transplanted  kidney or cause damage to the kidney in some other nonspecific 
fashion.  Accordingly,  three  B6AF~  mice,  which  had  received  B10.D2  kidney 
transplants at least 4 wk previously, were injected with 1.5 x  10  s normal B6AF1 
lymph node and spleen cells intraperitoneally on 2 successive days. No effect on 
BUN levels was observed during a subsequent month of observation. 
TREATMENT WITH DONOR STRAIN CELLS ALONE.  Four B6AF1 kidney recipients 
received 1.5  x  10  s pooled B10.D2 lymph node and spleen cells intraperitoneally 
on 2 successive days. An incresae in BUN levels was observed in all mice by the 
6  th  day  after  the  initial  cell  injection.  The  damage  induced  in  the  kidney 
transplants was transient,  however,  as BUN values steadily returned to near 
normal levels within 4 wk (see Fig.  3). Two of these four recipients underwent 1474  IMMUNE  DESTRUCTION  OF  LONG-TERM  RENAL  TRANSPLANTS  IN  MICE 
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FIG. 3.  The effect  of  donor cells  on transplant function.  Intraperitoneal  injections  of  1.5 
× 10  s  donor strain  lymph node and spleen  cells  on 2 succeeding days  resulted  in  elevations 
of  BUN  levels  in all four B6AFI mice which were long-term recipients  of  B10.D2 kidney 
transplants.  The damage provoked  by  these  cells  tended  to  be  repaired  gradually.  Injection 
of  the same number of  recipient  strain  cells  to three other animals (not  shown) failed  to 
induce any evidence of  transplant damage. 
splenectomy at  the height of  the induced response so  that their  spleens could  be 
assessed for  the presence of  killer  cells  as measured by 51Cr  release from P815- 
X2 target cells  (see  Fig.  4). Evidence of  only a sluggish immune response was 
revealed  by this test especially as compared  to the level of cell-mediated 
cytotoxicity  found in the spleens of animals which had recently received and 
rejected  skin grafts.  It was also  of  some interest  that removal of  the spleen at 
this point did not alter  the course of the response as compared to the other 
animals tested. 
TREATMENT WITH BCG AND CY.  BCG  (2 × 107  organisms) was given intrave- 
nously  to  two B6AFI mice with normally functioning B10.D2 kidney transplants 
at  8-15  wk. The BUN  levels  remained stable  thereafter  and were not  influenced 
adversely when an injection  of  CY (4 rag)  was given 20 days later (see  Fig.  5). 
TREATMENT  WITH  CY AND  DONOR  CELLS.  Five B6AFI recipients of B10.D2 
kidneys received injections  of  4 mg of  CY followed 2 days later  with the first  of 
two daily  intraperitoneal injections  of  1.5 × 10  s  B10.D2 spleen and lymph node 
cells.  By the 10th-12  th  days after  the initial  cell  injection  four out of  flve  of  the 
treated mice showed marked BUN  elevations and three of  these animals were 
sacrificed,  two with BUN  levels of over 200 rag/100 ml. The fourth animal 
recovered considerably  from the damage  incurred  and survived for several 
months.  The remaining transplant showed only a minor degree of damage 
during the observation period (see  Fig.  6). 
TREATMENT  WITH  BCG AND  DONOR  CELLS.  Four B6AFI recipients  of  B10.D2 
kidney transplants received injections  of  2 x 10  ~  BCG  organisms from 42 to 144 
days after  transplantation. On the 22  nd  and 23  rd  days after  BCG treatment, they 
received intraperitoneal injections  of 1.5 ×  108 B10.D2 lymphoid cells.  All of 
these  animals showed a sharp  rise  in  BUN  by  the 7  th-8th  day after  the  initial  cell P. S. RUSSELL,  C.  M.  CHASE,  R. B. COLVIN,  AND  J.  M.  D. PLATE  1475 
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FIG. 4.  Normal B6AFI animals, B6AF~ animals which had recently  rejected  B10.D2 skin 
grafts,  and B6AF1 recipients  of  B10.D2 kidneys were injected  i.p.  with 1.5 x 108 B10.D2 
lymphoid cells  8 and 9 days before  removal of  their  spleens.  Increasing numbers of  spleen 
cells  from each animal were mixed with 51Cr-labeled  P815-X2 cells  and incubated for  16 h 
before  the supernates were harvested. Spontaneous  release  (-  -  -) = 19.8%.  The capacity  of 
kidney transplant recipients  to produce cytotoxic  cells  in vivo under these conditions  was 
less  than  that  of  normal mice  and markedly less  than  that  specifically  immunized animals. 
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FIG. 5.  The administration of  BOG and CY in  the  dosages  indicated  failed  to  produce  any 
evidence of  renal damage in two control  B6AF~ mice which were long-term recipients  of 
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Fro. 6.  Treatment of  five  B6AF~ recipients  of  Bl0.D2 kidney  transplants with  CY followed 
by two daily  intraperitoneal injections  of donor strain lymphoid cells  rapidly provoked 
marked evidence of  renal damage in all but one animal the BUN  of which showed only 
moderate elevation. Three of the five animals became moribund and were sacrificed, 
whereas two recovered. 
injection. Three went on to severe uremia and were sacrificed when moribund. 
The fourth animal survived with a BUN at a slightly elevated level (see Fig. 7). 
TREATMENT WITH BCG, CY, AND DONOR CELLS.  AS further  controls for this 
particular  experiment,  two unilaterally  nephrectemized  B6AFI mice received 
injections of BCG and of CY 20 days later in the standard doses described. 2 and 
3 days after this  they received intraperitoneal  injections of 1.5  ×  108 B10.D2 
lymphoid cells. Their BUN levels remained normal throughout this period and 
for at least 30 days thereafter. 
Six  B6AF1  recipients  of  B10.D2  kidney  transplants  received  the  "triple 
treatment"  of BCG,  CY,  and  donor  strain  lymphoid  cells  according  to  the 
schedule described above. By the 6  th day after the first injection of B10.D2 cells, 
the BUN levels of all animals had begun to rise sharply.  All transplants  went 
on to complete cessation of function and their recipients were sacrificed as they 
became moribund (see Fig. 8). 
At sacrifice the spleens of three of these mice were removed and were tested 
in  vitro  for  cell-mediated  cytotoxicity to  donor  antigens  by evaluating  their 
ability to cause release of label from 51Cr-tagged PS15-X2 mastocytoma cells. As 
can be seen in Fig. 9, active killing of target cells was demonstrable in all cases 
even  at  low lymphocyte to  target  cell  ratios.  Such  killing  is  similar  to  that 
produced by cells from mice which have recently rejected skin grafts,  but has 
never been observed with cells from long-term kidney transplant  survivors (1). P.  S.  RUSSELL,  C.  M.  CHASE,  R.  B.  COLVIN,  AND  J.  M.  D.  PLATE  1477 
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FIG.  7.  Treatment of four B6AF~ recipients of B10.D2 kidneys with BCG followed 22 and 
23 days later with two intraperitoneal injections of 1.5  ×  108 donor strain lymphoid cells. 
Evidence of transplant damage was apparent by 7 days in all animals. In one of these, the 
damage failed to go to completion and the animal survived. 
No cytotoxic antibody was detected in serum from any of these three animals at 
the time they were sacrificed. 
To determine whether or not the allogeneic cell inoculum must share foreign 
specificities with the kidney transplant  to induce a damaging effect against it, 
two B6AF1 mice were employed which had born normally functioning B10.D2 
kidney transplants  for 69 days or more. Each was treated with BCG and CY as 
above, but the cell infusions were derived from A.SW donors.  Neither animal 
showed evidence of kidney damage  or alteration  in its state of apparent  well 
being during a period of several weeks of observation after the completion of the 
treatment. 
The "triple treatment"  regimen was also applied to four B6AF1 recipients of 
B10.BR kidney transplants.  Once  again,  by the  7 th day ai~r  the  first  donor 
strain cell injection, the BUN levels of all animals  became distinctly elevated 
from previously normal levels and all animals became fatally uremic by the 9 th 
day (see Fig.  10). A similar result was obtained with three B6AFI recipients of 1478  IMMUNE  DESTRUCTION  OF  LONG-TERM  RENAL  TRANSPLANTS  IN  MICE 
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FIG.  8.  Six B6AF~ recipients of  BI0.D2 kidney transplants received BCG, CY, and donor 
cells in the "triple treatment" program as indicated. All manifested severe renal damage 
by the 7  th or 8  ~h day and either died or required sacrifice  in a moribund state. 
H(zl) kidney transplants.  All mice became markedly uremic by the 6 th day and 
all were sacrificed in  a  preterminal  state by the  12 th day after the receipt of 
donor strain cells. 
Sections of fixed renal tissue were examined microscopically in a  number of 
instances and the morphologic findings are summarized in Table I. Transplants 
from untreated recipients showed minimal  focal mononuclear and plasma cell 
infiltrates that were localized principally around the vessels in about 5% of the 
cortex.  Large  arteries  tended  to  show  intimal  thickening  and  mononuclear 
infiltration,  and  the  glomeruli  manifested  moderately  extensive  focal  and 
segmental  scarring.  No  mononuclear  cell  accumulation  was  found  on  the 
endothelial surfaces. Kidney transplants from B10.BR and B10.D2 donors were 
examined  microscopically 6-7 days after donor cells were given in the "triple 
treatment"  regimen.  In  sharp  contrast  to  the  appearance  of kidneys  from 
untreated  recipients,  all  of  these  showed  an  intense,  diffuse  infiltrate  of 
mononuclear cells in the interstitium  and focally within tubules (Fig.  11). The 
most striking change was the accumulation Csticking") of mononuclear cells on 
arterial endothelial surfaces throughout the arterial system. These cells resem- 
bled lymphoblasts with basophilic cytoplasm and occasional nucleoli. Cells with 
indented nuclei, consistent in appearance with monocytes, were also present as 
well as occasional neutrophils.  Many arterial  lumena contained a  loose mesh- 
work of pale eosinophilic fibrillar material. The endothelial cells were occasion- 
ally basophilic; sometimes no endothelial nuclei were seen in an entire vessel 
cross section, indicating endothelial loss. However, necrotic endothelial cells or P.  S.  RUSSELL,  C.  M.  CHASE,  R.  B.  COLVIN,  AND  J.  M.  D.  PLATE  1479 
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FIG.  9.  B6AF~ recipients of BI0.D2  kidneys were treated with BCG,  CY,  and donor or 
recipient  strain  cells  as described  in the text.  Spleens from these animals  were removed 8 
days  after  the second  cell  injection  and the  splenic  ceils  were mixed in  increasing  numbers 
with ~2Cr-labe|ed  P815-X2 cells.  The supernates were harvested after  a 16-h incubation 
period.  Spontaneous release = 19.5%. Treatment with donor strain  cells  resulted  in the 
induction of  high levels  of  cell.mediated  cytotoxicity  which were not seen with recipient 
strain  cells. 
frank  thrombosis  were  not  identified.  Glomeruli  showed  segmental  damage 
with loss of architecture which was not significantly more severe than that seen 
in  untreated  animals.  Allografts from animals  which  had  received BCG and 
cells alone resembled in all respects those that received CY in addition. 
Discussion 
These experiments  shed some additional  light on the nature of the equilib- 
rium which is arrived  at spontaneously between graft  and  host in the strain 
combinations  studied.  The fact that  donor antigens  remain  on display on the 
surfaces  of donor  cells  is  affirmed  by  their  vulnerability  to  the  effects  of 
passively conferred immunity,  either humoral  or cell mediated.  Although  we 
have  no  information  regarding  possible changes  in  the  density  of such  cell 
surface antigens,  they appear to persist widely throughout the parenchyma of 
the kidney. In particular,  the intense and acute reaction which occurs against 
the  endothelium  of vessels in  transplants  after treatment  of their  recipients 
with BCG, CY, and donor strain lymphoid cells is evidence against the notion 
that graft endothelium is replaced by recipient cells with a period of 1 or 2 mo. 1480  IMMUNE  DESTRUCTION  OF  LONG-TERM  RENAL  TRANSPLANTS  IN  MICE 
200  f 
180  ~I/ 
E  mo  "Triple  Treatment"  ,  II 
140  4/4 died  l~ 
60 
20 
0  5  lO  15  20  2S  30  3S 
I'-2x107  4mg  CY  J  LL1.5x108  donor cells 
BCG org. 
DAYS 
Fro. I0.  Long-term B6AFI recipients  of  BI0.BR kidneys in which relatively  little  histo- 
incompatibility  is  involved  underwent the "triple  treatment" regimen outlined  in  the text. 
Without fail  all showed prompt evidence of rejection  which rapidly  destroyed all the 
transplants.  Primary kidney  transplants  in  this  strain  combination  are  rarely  rejected  (see 
text  and reference  15). 
TABLE  I 
Morphologic Features of Rejection  in Kidney Transplant Recipients after Receiving 
BCG, CY, and Donor Cells* 
Kidney  Number  Infiltrate  Glomer- 
and cell  Treatment  of ani-  Allograft  Days after  ular 
donor  age  donor cells  Intersti-  Endo-  damage 
strain  mals  tial  thelial 
days 
B10.D2  None  12  39-181  -  0/+  0  +/+ + + 
B10.D2  BCG/CY/Cells  3  132-347  7  + + +  + + +  + + 
B10.D2  BCG/Cells  2  76-182  11-12  + + +  + + +  + + + 
B10.BR  BCG/CY/Cells  3  61-72  6-7  + + +  + + +  + + + 
The findings  are described  in  detail  in the text. 
* The extent and intensity  of  the changes were scored  qualitatively  from 0 to ÷ + + +. P.  S.  RUSSELL,  C.  M.  CHASE,  R.  B.  COLVIN,  AND  J.  M.  D.  PLATE  1481 
The fact that no apparent damage to transplants was inflicted by the infusion 
of antibody specifically directed against  graft  antigens  without the  further 
addition  of rabbit  C  probably  attests  to  the  relative  inefficiency of mouse 
complement in such reactions. A similar result has been reported by Koene et 
al.,  who found that skin allotransplants between mice of the same strains as 
those used in  many of our experiments (B10.D2 to B6AFI) will be destroyed 
acutely only if infusions of antibody to the donor strain are supplemented with 
rabbit  complement (8). Another similar result was reported by French who 
found that acute destruction of rat kidney transplants,  surviving as a  conse- 
quence of infused  antibody  directed toward  donor  antigens  (immunological 
enhancement), could be induced by the administration of an effective comple- 
ment in the form of guinea pig serum (9). It is not clear exactly why the effects 
which  are  noted  on  the  function  of our  transplanted  mouse  kidneys after 
antibody and C treatment do not generally result in irreversible changes. The 
most likely explanation can probably be found, however, in the availability of 
sufficient quantities of all of the components required for the full expression of 
an inflammatory reaction rather than any lack of susceptibility of transplanted 
kidneys to such injury. Previous studies performed in our Unit of the damaging 
effects of infused antibody on surviving skin grafts established that although 
the ready availability of pelymorphonuclear leukocytes and complement are 
important  to  the  onward  progress  of antibody  mediated destruction,  other 
factors can participate in the process (10), W.  Soper and H. J.  Winn, personal 
communication. 
The donation to transplant recipients of large numbers of lymphoid cells from 
mice highly immunized to the kidney transplant antigens was demonstrated to 
produce a  definite impairment in renal function but only transiently. It was 
somewhat surprising that no definite increase in the destructive potential of 
cells transferred from preimmunized donors was seen with increasing doses. 
This result may be similar to those reported by Batchelor and Welsh and Bowen 
et al.  (11, 12). They found that rats, which can be made to accept transplanted 
kidneys for long periods by early treatment with antibody against donor strain 
antigens,  will  enter a  "steady state"  during which no further treatment is 
required for the continuing survival of the transplants.  The transfer of large 
numbers of specifically immunized lymphoid cells to these survivors, or even 
the parabiosis  of such recipients with syngeneic animals immunized to  the 
kidney transplant antigens, failed to bring about rejection of the transplanted 
tissue. In our system the available evidence suggests that an important point at 
which  interference with  the  normal  evolution  of the  immune response  to 
transplanted kidneys occurs is in the generation of killer T cells (1). It may be 
that even in cell populations from preimmunized donors, the number of active 
killer cells is relatively small and that the recruitment of additional killer cells 
is inhibited under the conditions prevailing in long-term transplant recipients. 
The above considerations make it particularly striking that the cell-mediated 
immune processes  of the  host  can  be  called  into  such  vigorous  action  by 
treatment with donor antigens reinforced by BCG,  CY,  or both.  These treat- 
ments can result in the complete rejection of a  transplant which the host is 
incapable of rejecting either through its  own active processes or even after 1482  IMMUNE  DESTRUCTION  OF  LONG-TERM  RENAL  TRANSPLANTS  IN  MICE 
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receiving large numbers of cells from specifically immunized donors.  Evidence 
that these regimens result in the generation of a vigorous cellular response lies 
both in the rapid appearance of killer cells in recipient spleens and lymph nodes 
and in the rich cellular infiltrate which is found in the transplanted  kidneys as 
they cease to function. Under the conditions tested so far, an indispensable part 
of the  treatment  regimen  is  the  inclusion  of a  disseminated  wave of donor 
specific antigens.  Although this stimulus,  on its own,  will result in a  readily 
detectable immune response to the transplant,  the response does not cause the 
complete  rejection  of any  transplants  and  loses  its  force  in  a  few days.  As 
reported  previously  (13),  the  application  of a  donor  strain  skin  graft  to  a 
surviving kidney transplant recipient results in no discernible reaction against 
the transplanted kidney. Indeed, donor strain skin grafts in this system survive 
for  prolonged  periods  and  their  rejection,  when  it  occurs,  is  very  gradual. 
Nevertheless,  the  vigor  of  the  acute  rejection  which  can  be  called  forth 
especially by the "triple treatment" regimen, in which all surviving transplants 
are  completely destroyed  in  7-8  days,  is  similar  in  tempo  to  an  accelerated 
reaction  which  would  ordinarily  occur  only  in  the  presence  of pre-existing 
immunity. Thus, even though kidney transplant recipients have been shown to 
be quite deficient in "memory cells" by in vitro tests,  by the time they have 
traversed  the  three  and  one  half weeks required  for  the  "triple  treatment" 
program they behave as though preimmunized.  Even though the administration 
of donor cells appears to be essential to the increase in the immune response 
which we have observed, supplementary treatment with CY and BCG has been 
required  to  provoke  rejection  in  all  transplants.  It  is  impressive  that  this 
treatment  is also effective even in the presence of the weaker immunogenetic 
disparity represented by B10.BR transplants  to B6AF1 recipients. 
The  mechanisms  to  be  considered  as  possible  contributors  to  this  sharp 
change in the balance between transplant  and host could lie in several areas, 
and each agent in the treatment program could play one or more roles. Among 
the  factors  to  be  considered  are:  (a)  influences  on  suppressor  cells,  (b)  the 
restoration of responsive cells to a  population made deficient in them through 
clonal deletion or inactivation,  or (c) effects on serum factors inhibitory to the 
evolution of a fully effective state of cell mediated immunity.  Our experimental 
observations are entirely consistent with those of Mackaness and Lagrange  (8) 
who designed the BCG and  CY treatment  regimen  we have used.  To restore 
delayed hypersensitivity reactions to their animals  additional  treatment  with 
antigen was required just as we find in our system. The precise requirements 
for the  antigenic  stimulus  and  timing  of delivery for the  components  of the 
FIO. 11.  Demonstration of morphological changes in transplanted kidneys after "triple 
treatment". (A) An allograft from an untreated mouse 134 days after transplantation. 
Little cellular infiltrate  is present (no. 535, ×  190). (B) An  allograft 132 days after 
transplantation.  The mouse received BCG, cyclophosphamide, and donor cells.  The last 
dose of  cells  was given 7 days before sacrifice.  The kidney shows an intense, widespread 
interstitial monuclear  infiltrate and  tubular damage.  The  segmental  obliteration of 
glomerular architecture illustrated  was also found in the controls (no. 571, x  190). (C) 
Longitudinal cross  section of  an artery in  the allograft  in Fig.  11B. Numerous cells,  largely 
mononuclear, have accumulated along the endothelial surface. Focal loss  of  endothelium 
has occurred (no.  571, x 430).  All sections are from B10.D2 to B6AF I  transplants. 1484  IMMUNE  DESTRUCTION  OF  LONG-TERM  RENAL  TRANSPLANTS  IN  MICE 
treatment  have not been established in kidney transplant  recipients.  Macka- 
hess  and  Lagrange  postulated  that  the  influence  of CY  in their  system was 
attributable  to  its  selective  inactivation  of B  cells  which  thus  resulted  in  a 
reduction in antibody levels and consequently in antibody feedback inhibition 
of T-cell activity. BCG was believed to interfere with "serum blocking factors". 
Only a preliminary consideration of the various mechanisms is possible from 
the experiments reported in this communication and the accompanying paper 
(1).  We have  demonstrated  that  our  animals  do not  manifest  marked  T-cell 
unresponsiveness to donor antigens,  i.e.,  they are not tolerant  in the conven- 
tional sense, and no direct evidence to support the presence of suppressor cells 
has been uncovered. Thus, however plausible it might be, we cannot attribute 
the action of CY to a depletion of suppressor T cells as it is reportedly capable of 
producing in some systems (14). Humoral antibody with complement-dependent 
cytotoxic activity for donor cells can be detected in low titers, especially in the 
early weeks after transplantation,  in some B6AF1 recipients of B10.D2 kidneys, 
but current  evidence makes it unlikely that  suppression of T-cell function by 
antibody directed to H-2 determined histocompatibility antigens could be a full 
explanation  for  the  long-term  survival  of these  transplants.  This  evidence 
includes  the  fact  that  kidneys  transplanted  from  H(zl)  donors  to  B6AF1 
recipients survive very well even though no humoral antibody to donor cells in 
this strain combination can be produced by a variety of methods. Nevertheless, 
there  is  evidence  for  the  presence  of a  substance  in  the  sera  of long-term 
recipients  which  inhibits  the  ability  of nonimmune  cells to differentiate  into 
effector  cells  (1).  We  have  not  yet  made  efforts  to  determine  whether  this 
substance is eliminated by the "triple treatment"  regimen,  but it would seem 
logical to expect that this might be at least one of its results. 
Whatever the mechanisms may be for the generation of this marked immu- 
nological reaction,  they do not appear to result in potentiation of the humoral 
arm of the response since no evidence of cytotoxic antibody production could be 
detected  after  the  "triple  treatment".  These  results  serve  to  emphasize  the 
complexity of the immune relationship which can exist between a vascularized 
mass of cells bearing foreign surface antigens  and its host.  That this immune 
balance can be so decisively upset should stand as a point of caution in clinical 
organ transplantation  but perhaps as a source of encouragement to oncologists. 
Summary 
Various  modes for producing  the  specific immune  destruction  of surviving 
kidney  transplants  between mice  were tested  in  these  experiments.  Kidney 
transplants  among mice which were incompatible at the H-2 locus but which 
were  surviving  in  excellent  condition  for  several  weeks  without  immuno- 
suppression  were  utilized  as  subjects for  these  experiments.  When  immune 
damage to these surviving organs resulted from the treatments being tested it 
was readily  detectable by changes  in  the  blood urea  nitrogen  levels of their 
recipients. The treatments included means of heightening immune reactivity to 
donor antigens  passively by the  transfer  of either  specifically activated cells, 
immune serum, or by the active generation of increased responsiveness. 
Infusions  of an  antiserum  specifically reactive  with  the  histocompatibility P.  S.  RUSSELL,  C.  M.  CHASE,  R.  E.  COLVIN,  AND  J.  M.  D.  PLATE  1485 
antigens of the transplant were ineffective in causing damage to the kidney 
unless exogenous complement, in the form of  rabbit serum absorbed with mouse 
tissue,  was  also  given.  The  injection  of lymph node  and  spleen  cells  from 
recipient  strain  mice  which  had  been  highly immunized to  donor  antigens 
caused definite but transient damage to transplanted kidneys. 
Stimulation of recipient responsiveness by additional donor tissue antigens 
presented  as  skin  grafts  was  ineffective although  intravenous  injections  of 
lymphoid  cells  provoked  an  evanescent  reaction.  Combining  donor  strain 
lymphoid cell treatment with a  prior injection of cyclophosphamide (4  rag,  2 
days before cell injection) and/or treatment with Bacille of Calmette and Gudrin 
(2  ×  107 organisms, 22 days before cell injection) caused an intense and specific 
immune response to donor antigens with rapid onset of  transplant damage. The 
maximal effect observed followed the combined use of all three agents in which 
case every transplant was fully rejected by 7 or 8 days after donor cell injection. 
These  results  demonstrate  that  an  otherwise  stable  balance  between  an 
incompatible  transplanted  organ  and  its  host  can  be  decisively  upset  by 
treatments which provoke a heightened, specific immune response. The confer- 
ral of immunity passively by transferring either serum or lymphoid cells from 
sensitized donors was much less successful in causing damage to transplants. 
This  information must be  interpreted  in  the  light  of the  evidence we  have 
presented in an accompanying paper (1) that the maturation of fully competent 
killer T cells is retarded in long-term kidney transplant recipients and that no 
direct evidence of suppressor cell activity can be found in them. The fact that 
only transient damage to transplants occurred even after the transfer of large 
numbers  of immunized lymphoid cells,  however,  has  made  us  refrain  from 
dismissing altogether the participation of an active suppressor mechanism. 
We would like to acknowledge the effective aid of Ms.  Susan W. Ayres in the preparation of the 
manuscript and the helpful comments of Dr.  Henry J.  Winn. 
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